X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $28.33 | -619 | 182,558 | 0% | -$17,536 | ||||||
2023-12-14 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $20.76 | -514 | 182,672 | 0% | -$10,671 | ||||||
2023-09-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $50.34 | -531 | 150,689 | 0% | -$26,731 | ||||||
| D | 2023-06-16 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $54.78 | -78,200 | 151,220 | -34% | -$4,284,066 | |||||
2023-06-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $55.16 | -509 | 189,420 | 0% | -$28,076 | ||||||
| DM | 2022-12-28 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $50.97 | -22,016 | 190,532 | -10% | -$1,122,125 | |||||
| M | 2022-11-15 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $45.28 | -7,085 | 183,837 | -4% | -$320,806 | |||||
| DM | 2022-10-25 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $45.07 | -15,415 | 190,922 | -7% | -$694,782 | |||||
| AD | 2022-09-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $29.18 | -22,500 | 233,837 | -9% | -$656,550 | |||||
| D | 2022-10-06 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $39.29 | -22,500 | 186,337 | -11% | -$884,025 | |||||
| D | 2022-09-30 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $32.72 | -45,000 | 198,837 | -18% | -$1,472,400 | |||||
2022-09-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $29.18 | -22,500 | 223,837 | -9% | -$656,550 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |